[ Price : $8.95]
Federal Register Notice: CDER plans to continue the Regulatory Project Management Site Tours and Regulatory Interaction Program an...[ Price : $8.95]
FDA clears a Nanosphere, Inc. 510(k) for the Verigene F5 / F2 / MTHFR Nucleic Acid Test for detecting disease-associated gene muta...[ Price : $8.95]
Bipartisan congressional overseers find FDAs foreign drug inspections in China and India are still hampered by resource limitation...[ Price : $8.95]
Former FDA deputy chief counsel Gerald F. Masoudi rejoins FDA as its new chief counsel.[ Price : $8.95]
FDA issues a safety alert on Amylin Pharmaceuticals Type 2 diabetes drug Byetta after reviewing 30 postmarketing reports of acute ...[ Price : $8.95]
Sidney Wolfe asks why FDA didnt order a recall of Medtronic Sprint Fidelis defibrillators much earlier this year when reports of a...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Alternative Health Approaches, Dialysis Dimensions, EM Probe, and Washington Hos...[ Price : $8.95]
FDA approves BMS new chemotherapy drug Ixempra (ixabepilone) to treat advanced breast cancer in women whose tumors are resistant t...